GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Codexis Inc (FRA:4QK) » Definitions » Other Stockholders Equity

Codexis (FRA:4QK) Other Stockholders Equity : €-0.00 Mil (As of Sep. 2024)


View and export this data going back to 2010. Start your Free Trial

What is Codexis Other Stockholders Equity?

Codexis's Other Stockholders Equity for the quarter that ended in Sep. 2024 was €-0.00 Mil.

Codexis's quarterly Other Stockholders Equity declined from Mar. 2024 (€0.00 Mil) to Jun. 2024 (€-0.00 Mil) and declined from Jun. 2024 (€-0.00 Mil) to Sep. 2024 (€-0.00 Mil).

Codexis's annual Other Stockholders Equity declined from Dec. 2021 (€0.00 Mil) to Dec. 2022 (€0.00 Mil) but then increased from Dec. 2022 (€0.00 Mil) to Dec. 2023 (€0.00 Mil).

Codexis Other Stockholders Equity Historical Data

The historical data trend for Codexis's Other Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Codexis Other Stockholders Equity Chart

Codexis Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Other Stockholders Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Codexis Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Other Stockholders Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Codexis Other Stockholders Equity Calculation

Other Stockholders Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. GuruFocus lists following items in "Total Stockholders Equity" section:
Common Stock
Preferred Stock
Retained Earnings
Accumulated other comprehensive income (loss)
Additional Paid-In Capital
Treasury Stock
Other Stockholders Equity

Codexis Other Stockholders Equity Related Terms

Thank you for viewing the detailed overview of Codexis's Other Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Codexis Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Codexis Inc (FRA:4QK) » Definitions » Other Stockholders Equity
Comparable Companies
ENGN RENB IMRX XOMA TSVT DRTS GOSS CRMD PBYI ALDX OCSE:NOVO B VRTX REGN ASX:CSL SGEN XKRX:207940 MRNA XKRX:068270 BNTX ALNY
Traded in Other Exchanges
CDXS:USA 0I0X:UK 4QK:Germany
Address
200 Penobscot Drive, Redwood, CA, USA, 94063
Website
https://www.codexis.com
Codexis Inc is involved in the business of providing enzyme optimization services, commercialization of proteins, and developing biocatalyst products, leveraging its proprietary CodeEvolver directed evolution technology platform. The firm's products and services include Biocatalysts and Enzymes. The company generates majority of its revenue through product sales and also licenses its technology platform CodeEvolver to pharmaceutical companies enabling them to use this technology, in-house, to engineer enzymes for their own businesses. Geographically, it derives revenue from the United States, Ireland, Switzerland, China and other markets.

Codexis Headlines

No Headlines